The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth of the market is driven mainly by the increasing number of breast augmentation surgeries and rising awareness of cosmetic surgeries.
Key Market Players:
Johnson Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health Aesthetics (Germany), Sientra (US), Establishment Labs S.A. (Costa Rica), Silimed (Brazil), Laboratories Arion (France), Guangzhou Wanhe Plastic Materials (China), CEREPLAS (France), HansBiomed (South Korea), and Shanghai Kangning Medical Device Co. (China)
Download a FREE Sample Report PDF of the Global Breast Augmentation Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239683866utm_source=Ganeshutm_medium=P
This research report categorizes the breast augmentation market into the following segments and sub-segments:
By Product
- Silicone Breast Implant
- Saline Breast Implant
By Shape
- Round Shape
- Anatomical Shape
By Surface
- Smooth
- Textured
By Procedure
- Inframammary Fold
- Trans-axillary
- Perio-aeriolar
- Trans-umbical
By End User
- Hospitals
- Cosmetology Clinics and Ambulatory Care Settings
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- RoE
- Asia Pacific
- China
- India
- Japan
- RoAPAC
- Rest of the World
The silicone breast implants segment is expected to grow at the highest CAGR during the forecast period
Based on the product, the breast augmentation market is segmented into silicone breast implant and saline breast implant. The silicone breast implant segment is projected to witness the highest growth during the forecast period. The increasing number of breast augmentation procedures and rising awareness of cosmetic surgeries are the major factors supporting the growth of this segment.
The inframammary fold segment accounted for the largest share of the breast augmentation industry
By procedure, the market is segmented into inframammary fold, trans-axillary, periareolar, and trans-umbilical procedures. The inframammary fold segment accounted for the largest market share in 2019. The large share of this segment can be attributed to the increasing number of breast augmentation procedures.
Hospitals accounted for the largest share of the breast augmentation industry
Based on end-users, the global market is segmented into hospitals, cosmetology clinics and ambulatory care settings, and other end users. The hospital segment accounted for the largest share of the global market in 2019. The increasing number of breast augmentation procedures and rising awareness of cosmetic procedures are some of the major factors responsible for the high demand for breast augmentation products such as breast implants.
Direct Purchase of the Global Breast Augmentation Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=239683866utm_source=Ganeshutm_medium=P
North America accounted for the largest share of the breast augmentation industry
Based on the region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the breast augmentation market. The large share of North America can be attributed to factors such as the increasing number of breast augmentation procedures and rising awareness of cosmetic surgeries
Some of the major players operating in this market are Johnson and Johnson (US), Allergan (Ireland), and Sientra (US). In 2019, Johnson and Johnson held the leading position in the market. The company has a presence in more than 60 countries. Moreover, the company’s strong brand recognition and comprehensive product portfolio in the global market is its key strength. Allergan held the second position in the global market in 2019.
